These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 30817743

  • 1. Down-Regulation of Nfatc1 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Prostate Cancer Cells.
    Liu Y, Liang T, Qiu X, Ye X, Li Z, Tian B, Yan D.
    Med Sci Monit; 2019 Feb 28; 25():1572-1581. PubMed ID: 30817743
    [Abstract] [Full Text] [Related]

  • 2. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.
    Kawahara T, Kashiwagi E, Ide H, Li Y, Zheng Y, Ishiguro H, Miyamoto H.
    Prostate; 2015 May 28; 75(6):573-84. PubMed ID: 25631176
    [Abstract] [Full Text] [Related]

  • 3. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
    Manda KR, Tripathi P, Hsi AC, Ning J, Ruzinova MB, Liapis H, Bailey M, Zhang H, Maher CA, Humphrey PA, Andriole GL, Ding L, You Z, Chen F.
    Oncogene; 2016 Jun 23; 35(25):3282-92. PubMed ID: 26477312
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
    Miao Y, Lu M, Yan Q, Li S, Feng Y.
    Oncol Res; 2016 Oct 27; 24(6):463-475. PubMed ID: 28281967
    [Abstract] [Full Text] [Related]

  • 5. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L, Duan Z, Yu J, Dang HX.
    Oncol Rep; 2016 Aug 27; 36(2):918-28. PubMed ID: 27350254
    [Abstract] [Full Text] [Related]

  • 6. PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.
    Li C, Zhao Z, Zhou Z, Liu R.
    Dig Dis Sci; 2016 Mar 27; 61(3):767-73. PubMed ID: 26500118
    [Abstract] [Full Text] [Related]

  • 7. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
    Yuan Q, Yu H, Chen J, Song X, Sun L.
    Exp Cell Res; 2018 Jan 01; 362(1):209-216. PubMed ID: 29155364
    [Abstract] [Full Text] [Related]

  • 8. PKM2 and HIF-1α regulation in prostate cancer cell lines.
    Hasan D, Gamen E, Abu Tarboush N, Ismail Y, Pak O, Azab B.
    PLoS One; 2018 Jan 01; 13(9):e0203745. PubMed ID: 30216369
    [Abstract] [Full Text] [Related]

  • 9. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
    Guo Z, Liu D, Su Z.
    Tumour Biol; 2015 Jun 01; 36(6):4777-83. PubMed ID: 25636449
    [Abstract] [Full Text] [Related]

  • 10. miR-361-5p modulates metabolism and autophagy via the Sp1-mediated regulation of PKM2 in prostate cancer.
    Ling Z, Liu D, Zhang G, Liang Q, Xiang P, Xu Y, Han C, Tao T.
    Oncol Rep; 2017 Sep 01; 38(3):1621-1628. PubMed ID: 29094170
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
    Zhou YJ, Yang HQ, Xia W, Cui L, Xu RF, Lu H, Xue Z, Zhang B, Tian ZN, Cao YJ, Xing ZY, Yin S, He XZ.
    Life Sci; 2017 Dec 01; 190():7-14. PubMed ID: 28943214
    [Abstract] [Full Text] [Related]

  • 12. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
    Eerola SK, Santio NM, Rinne S, Kouvonen P, Corthals GL, Scaravilli M, Scala G, Serra A, Greco D, Ruusuvuori P, Latonen L, Rainio EM, Visakorpi T, Koskinen PJ.
    Cell Commun Signal; 2019 Nov 15; 17(1):148. PubMed ID: 31730483
    [Abstract] [Full Text] [Related]

  • 13. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X, Zhou Y, Chen W, Chen L, Lu J, He F, Li X, Zhao L.
    Cell Physiol Biochem; 2018 Nov 15; 51(3):1340-1353. PubMed ID: 30481782
    [Abstract] [Full Text] [Related]

  • 14. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
    Zhou Y, Ji Z, Yan W, Zhou Z, Li H.
    Oncol Rep; 2017 Sep 15; 38(3):1411-1419. PubMed ID: 28713997
    [Abstract] [Full Text] [Related]

  • 15. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
    Guo Z, Liu D, Su Z.
    Tumour Biol; 2015 May 15; 36(5):3583-9. PubMed ID: 25560487
    [Abstract] [Full Text] [Related]

  • 16. UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy.
    Wan X, Yang S, Huang W, Wu D, Chen H, Wu M, Li J, Li T, Li Y.
    J Exp Clin Cancer Res; 2016 Feb 17; 35():34. PubMed ID: 26884069
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J, Cheng G, Li X, Pan Y, Qin C, Yang H, Hua L, Wang Z.
    Tumour Biol; 2016 Jul 17; 37(7):9603-13. PubMed ID: 26797783
    [Abstract] [Full Text] [Related]

  • 18. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
    Guo M, Zhao X, Yuan X, Jiang J, Li P.
    Oncotarget; 2017 Apr 25; 8(17):28226-28236. PubMed ID: 28415668
    [Abstract] [Full Text] [Related]

  • 19. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J, Bian C, Wang H, Huang S, Wu D.
    J Exp Clin Cancer Res; 2015 Jan 31; 34(1):8. PubMed ID: 25636908
    [Abstract] [Full Text] [Related]

  • 20. NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway.
    Xu W, Gu J, Ren Q, Shi Y, Xia Q, Wang J, Wang S, Wang Y, Wang J.
    Tumour Biol; 2016 Apr 31; 37(4):4493-500. PubMed ID: 26501422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.